Biliary Tract Neoplasms: all 492 studies
Page 5 of 5. Open to participants first (191), then studies with results posted, then the rest; newest registration first within each.
- Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract CancerCompletedNCT03044587Phase 2
- Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTCTerminatedNCT02992340Phase 1/2
- Early Palliative Care on Quality of Life of Advanced Cancer PatientsCompletedNCT02988635Phase 3
- Study of Surufatinib as Second-line Treatment in Patients With Biliary Tract CarcinomaCompletedNCT02966821Phase 2
- The Effect of Individualized Precision Therapy Programs in Patients With BTCStatus unknownNCT02943031Phase 4
- Liver and Biliary Tumor Tissue RegistryTerminatedNCT02917759
- A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary CancerTerminatedNCT02908451Phase 1
- Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer PatientsCompletedNCT02866383Phase 2
- The Role of ctDNA and PBMC in Treatment of Biliary Tract CancerStatus unknownNCT02809898
- Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP MalignancyCompletedNCT02784353Not applicable
- MEK162 in Combination With Capecitabine in Advanced Biliary Tract CancerCompletedNCT02773459Phase 1/2
- Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract CancersWithdrawnNCT02720601Phase 2
- Precise Treatment in Hepatobiliary Cancers (PTHBC)Status unknownNCT02715089
- Parenteral Nutrition in Patients With Biliopancreatic Mass LesionsCompletedNCT02670265Not applicable
- Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary TractStatus unknownNCT02632019Phase 1/2
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Active, not recruitingNCT02628067Phase 2
- Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary StricturesTerminatedNCT02615210Not applicable
- A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507WithdrawnNCT02597465Phase 3
- A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid TumoursCompletedNCT02586987Phase 1
- A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsCompletedNCT02576431Phase 2
- Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract CancerCompletedNCT02558959Phase 2
- Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract CancerStatus unknownNCT02527824Phase 2
- Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract CancerCompletedNCT02433639Phase 2
- A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract CancerCompletedNCT02425137Phase 2
- ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT02351765Phase 1
- XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based ChemotherapyStatus unknownNCT02350686Phase 2
- Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract AdenocarcinomaCompletedNCT02346032Phase 2
- Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary ObstructionStatus unknownNCT02255669Not applicable
- Radioactive Stents for Treatment of Unresectable Biliary Tract CancerStatus unknownNCT02238613Not applicable
- Multibending vs Conventional Endoscope for Direct Peroral CholangioscopyStatus unknownNCT02189421Not applicable
- GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract CancerCompletedNCT02182778Phase 3
- Gemcitabine and S-1 for Advanced Biliary Tract CancerCompletedNCT02146703Phase 2
- Covered Versus Uncovered Biliary Stents for Biliary MalignanciesCompletedNCT02102984Not applicable
- Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain ControlCompletedNCT02002806Not applicable
- Evolution® Biliary Stent System Clinical StudyCompletedNCT01962168
- Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT01926236Phase 3
- Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract CancerCompletedNCT01917617Phase 2
- X-MAS Biliary Study With Covered Biliary StentCompletedNCT01899976Not applicable
- Vessel Resection and Reconstruction of Biliary Tract CancersCompletedNCT01861483
- GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract CancerStatus unknownNCT01859728Phase 2
- ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract CancerCompletedNCT01825603Phase 1
- A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node MetastasisStatus unknownNCT01821248Phase 2
- Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract CancerCompletedNCT01815307Phase 2
- SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic CancerStatus unknownNCT01811277Phase 2
- Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary CancerTerminatedNCT01773785Phase 2
- Radiofrequency Ablation for Malignant Biliary ObstructionCompletedNCT01758341Phase 4
- Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After PancreaticoduodenectomyCompletedNCT01731821Phase 3
- A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major HepatectomyCompletedNCT01713387Phase 1
- Duct-to-mucosa Versus Invagination for PancreaticojejunostomyStatus unknownNCT01695447Not applicable
- Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary SurgeryCompletedNCT01657383
- MRCP Diagnoses EHCC Better When Combined DWICompletedNCT01595217Not applicable
- Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PBCompletedNCT01589328Not applicable
- Study of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasCompletedNCT01572324Phase 2
- Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for CancerStatus unknownNCT01542281Not applicable
- Second Line Therapy in Advanced Biliary Tract CancerCompletedNCT01530503Phase 2
- Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract CancerStatus unknownNCT01494363Phase 2
- Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract AdenocarcinomaCompletedNCT01375972Phase 2
- Covered vs. Uncovered SEMS for Occluded Biliary Metal StentsCompletedNCT01315522Phase 4
- A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major HepatectomyCompletedNCT01297998Phase 1
- Case Series Study of Biliary Tract Cancer Patients in JapanCompletedNCT01294085
- Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract CancerCompletedNCT01291615Phase 1
- Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract CancerCompletedNCT01284413Phase 1/2
- ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract CancerCompletedNCT01242605Phase 1
- Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract CancerStatus unknownNCT01234051Phase 2
- Cetuximab + Gemox in Biliary Tract CancerCompletedNCT01216345Phase 2
- Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)Status unknownNCT01180153Phase 2
- Phase II Study of Gemcitabine and TS-1 in Biliary Trat CancerTerminatedNCT01171755Phase 2
- Salvage mFOLFOX in BTC After Failure of GemcitabineCompletedNCT01127555Phase 2
- Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary CancerTerminatedNCT01096745Phase 2
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant ObstructionCompletedNCT00980889Phase 4
- Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract CancersCompletedNCT00939848Phase 2/3
- Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract CancerCompletedNCT00832689Phase 2
- Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II StudyCompletedNCT00747097Phase 2
- Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)TerminatedNCT00630890Phase 1
- Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary CancersCompletedNCT00626158Phase 1
- Biliary Cancers: EGFR INhibitor, Gemcitabine and OxaliplatinCompletedNCT00552149Phase 2
- Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary CancerWithdrawnNCT00487851Phase 2
- Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CompletedNCT00423254Phase 1
- Endoscopic Stenting of Gastrointestinal CancerCompletedNCT00422409Not applicable
- Storage of Bile From Routine Procedures to Study Risk FactorsTerminatedNCT00414843
- Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract CancerCompletedNCT00363584Phase 3
- A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing PancreaticoduodenectomyTerminatedNCT00359320Not applicable
- A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, ChinaCompletedNCT00339560
- The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary CancerCompletedNCT00268840Phase 2
- EXIBIT: Oxaliplatin in Biliary Tract CancerCompletedNCT00174564Phase 2
- Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerCompletedNCT00142480Phase 2
- Gemcitabine and Cisplatin for Gallbladder and Biliary Tract CancerCompletedNCT00123825Phase 2
- XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary TumorsTerminatedNCT00090025Phase 3
- Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT00073905Phase 2